Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « ace »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
accurate < ace < acetic  Facettes :

List of bibliographic references indexed by ace

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000181 (2021) Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde]Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
000480 (2021) Anamika Gupta [Inde] ; Rumana Ahmad [Inde] ; Sahabjada Siddiqui [Inde] ; Kusum Yadav [Inde] ; Aditi Srivastava [Inde] ; Anchal Trivedi [Inde] ; Bilal Ahmad [Inde] ; Mohsin Ali Khan [Inde] ; Amit Kumar Shrivastava [Népal] ; Girish Kumar Singh [Inde]Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis.
000567 (2021) Jung-Soo Suh [Corée du Sud] ; Heon-Su Kim [Corée du Sud] ; Tae-Jin Kim [Corée du Sud]Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor.
000645 (2021) Riadh Badraoui [Arabie saoudite, Tunisie] ; Mohd Adnan [Arabie saoudite] ; Fevzi Bardakci [Arabie saoudite, Turquie] ; Mousa M. Alreshidi [Arabie saoudite]Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
000652 (2021) Jia Fu [République populaire de Chine] ; Qianqian Jia [République populaire de Chine] ; Huaxin Zhou [République populaire de Chine] ; Liyang Zhang [République populaire de Chine] ; Saisai Wang [République populaire de Chine] ; Peida Liang [République populaire de Chine] ; Yanni Lv [République populaire de Chine] ; Shengli Han [République populaire de Chine]Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
000758 (2021) Lorenzo A. Cal [Italie] ; Matteo Rigato [Italie] ; Luca Sgarabotto [Italie] ; Lisa Gianesello [Italie] ; Giovanni Bertoldi [Italie] ; Verdiana Ravarotto [Italie] ; Paul A. Davis [États-Unis]ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes.
000C55 (2020) Rajkumar Singh Kalra [Japon] ; Dhanendra Tomar [États-Unis] ; Avtar Singh Meena [Inde] ; Ramesh Kandimalla [Inde]SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.
000F32 (2020) Yuan Hou [États-Unis] ; Junfei Zhao [États-Unis] ; William Martin [États-Unis] ; Asha Kallianpur [États-Unis] ; Mina K. Chung [États-Unis] ; Lara Jehi [États-Unis] ; Nima Sharifi [États-Unis] ; Serpil Erzurum [États-Unis] ; Charis Eng [États-Unis] ; Feixiong Cheng [États-Unis]New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.
000F42 (2020) Priyanka Sharma [Inde] ; Asifkhan Shanavas [Inde]Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis.
000F43 (2020) Lanlan Zhou ; Kelsey Huntington ; Shengliang Zhang ; Lindsey Carlsen ; Eui-Young So ; Cassandra Parker ; Ilyas Sahin ; Howard Safran ; Suchitra Kamle ; Chang-Min Lee ; Chun Geun Lee ; Jack A. Elias ; Kerry S. Campbell ; Mandar T. Naik ; Walter J. Atwood ; Emile Youssef ; Jonathan A. Pachter ; Arunasalam Navaraj ; Attila A. Seyhan ; Olin Liang ; Wafik S. El-DeiryNatural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells.
000F64 (2020) Hadjer Khelfaoui [Algérie] ; Dalal Harkati [Algérie] ; Basil A. Saleh [Iraq]Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2.
000F66 (2020) Meshari Alazmi [Arabie saoudite] ; Olaa MotwalliMolecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates.
001625 (2020) Nan Wang [République populaire de Chine] ; Shengli Han [République populaire de Chine] ; Rui Liu [République populaire de Chine] ; Liesu Meng [République populaire de Chine] ; Huaizhen He [République populaire de Chine] ; Yongjing Zhang [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yanni Lv [République populaire de Chine] ; Jue Wang [République populaire de Chine] ; Xiaowei Li [République populaire de Chine] ; Yuanyuan Ding [République populaire de Chine] ; Jia Fu [République populaire de Chine] ; Yajing Hou [République populaire de Chine] ; Wen Lu [République populaire de Chine] ; Weina Ma [République populaire de Chine] ; Yingzhuan Zhan [République populaire de Chine] ; Bingling Dai [République populaire de Chine] ; Jie Zhang [République populaire de Chine] ; Xiaoyan Pan [République populaire de Chine] ; Shiling Hu [République populaire de Chine] ; Jiapan Gao [République populaire de Chine] ; Qianqian Jia [République populaire de Chine] ; Liyang Zhang [République populaire de Chine] ; Shuai Ge [République populaire de Chine] ; Saisai Wang [République populaire de Chine] ; Peida Liang [République populaire de Chine] ; Tian Hu [République populaire de Chine] ; Jiayu Lu [République populaire de Chine] ; Xiangjun Wang [République populaire de Chine] ; Huaxin Zhou [République populaire de Chine] ; Wenjing Ta [République populaire de Chine] ; Yuejin Wang [République populaire de Chine] ; Shemin Lu [République populaire de Chine] ; Langchong He [République populaire de Chine]Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "ace" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "ace" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    ace
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021